Skip to content

McKesson MCK Medical-Surgical Solutions — Goodwill acquired

Other segment segments

Prescription Technology Solutions
$39M
Oncology & Multispecialty
$28M
North American Pharmaceutical
$0

Similar metrics at other companies

Aveanna Healthcare Holdings Inc. logo
AVAHMedical Solutions — Goodwill Acquired
$0
Novanta logo
NOVTMedical Solutions — Goodwill
$316.9M+14.8%
Boston Scientific logo
BSXMedSurg — Goodwill acquired
$274M
Novanta logo
NOVTMedical Solutions — Goodwill Gross
$348.62M+13.3%
Novanta logo
NOVTMedical Solutions — Goodwill Impaired Accumulated Impairment Loss
$31.72M0.0%
Solventum logo
SOLVMedSurg — Goodwill
$4.18B+13.9%

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$104.14B+17.1%
Enterprise value$102.44B+5.1%
P/E21.9×-6.2×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's medical-surgical solutions — goodwill acquired.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's medical-surgical solutions — goodwill acquired?
McKesson (MCK) reported medical-surgical solutions — goodwill acquired of $0 in Q1 2026.
What does medical-surgical solutions — goodwill acquired mean?
This metric tracks the amount of new goodwill recognized on the balance sheet specifically from acquisitions completed within the Medical-Surgical Solutions segment during the reporting period. It highlights the capital allocated toward inorganic growth.